Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

DEPAKENE vs STAVZOR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate
depakenestavzor

Rating

72/100
70/100

Pharmacy pays

~$1.02 /30
~$1.02 /30

Type

RX
RX

Active ingredient

VALPROIC ACID
VALPROIC ACID

Manufacturer

Abbvie
Bionpharma

Dosage forms

Syrup, Capsule
Capsule, delayed release

Drug class

Anti-Epileptic Agent
Anti-Epileptic Agent

Boxed warning

None
None

Treats

Alzheimer Disease, Bipolar Disorder, Epilepsy
Alzheimer Disease, Bipolar Disorder, Epilepsy

Frequently asked questions

Which is better-rated, Depakene or Stavzor?

By our independent rating, Depakene scores higher — 3.6 vs 3.5 out of 5 for Stavzor. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Depakene or Stavzor?

Pharmacies pay about the same to acquire either one — roughly $1.02 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Depakene and Stavzor?

Both Depakene and Stavzor share the active ingredient Valproic Acid.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.